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 먼저 부족한 저에게 많은 기회를 주시고 지도해 주신 최인홍 교수님께 말로는 
다 할 수 없는 감사 드립니다. 아무것도 몰랐던 저에게 나노라는 새로운 길을 가
르쳐 주시고, 항상 보듬어 주시고, 격려해 주셨기에 여기까지 올 수 있었던 것 같
습니다. 지도교수님 이상으로서 어머니처럼 6년간 저를 이끌어 주심을 잊지 않도
록 하겠습니다. 언제나 미생물학교실 주임 교수님으로서, 이번에는 심사위원으로
서 마지막까지 도움을 주신 신전수 교수님께 감사의 말씀 드립니다. 항상 나노 
물질 합성에 도움을 주셨고, 이번에도 논문 지도를 맡아주신 이강택 교수님께 감
사를 드립니다. 또한 언제나 따뜻한 관심으로 논문 지도를 해주신 김동현 교수님
과 유일제 교수님께 감사의 말씀 드립니다. 제가 생활하던 미생물학교실의 조상
래 교수님, 박전한 교수님, 김종선 교수님, 이재면 교수님, 윤상선 교수님, 유제욱 
교수님, 신성재 교수님, 나노메디컬 협동과정의 유경화 교수님, 실험에 도움을 주
셨던 이광훈 교수님, 박승우 교수님, 김세훈 교수님 많은 교수님들의 도움으로 학
위를 마무리 할 수 있었습니다. 감사합니다. 
지금은 질병관리본부에 계시지만 대학원 생활 중 항상 곁에서 격려와 응원을 
해주신 양은정 박사님, 언제나 든든한 형처럼 옆을 지켜준 진원형, 어리버리한 후
배 잘 이끌어주신 든든한 사수 지영샘, 마지막까지 함께해준 유일한 후임 한구 
덕분에 실험실 생활이 즐거웠던 것 같습니다. 짧은 시간이었지만 많은 도움 주신 
장영생 박사님께도 감사 드립니다. 또한 항상 나노 물질 합성에 도움을 주셨던 
강태경 선생님, 아토피 연구에 도움을 주신 김산 선생님 감사합니다. 
 
 
또한 대학원 생활 중에 언제나 도움을 주신 고시환 선생님, 최영미 선생님, 곽
만섭 박사님, 오영택 박사님, 김주영 박사님 감사합니다. 나노메디컬 협동과정으
로서 항상 듬직하게 도움을 준 영욱이형, 희열이형, 현국형 감사합니다. 지금은 
졸업하였지만 지유, 정현, 형준이 덕분에 많은 도움을 받았습니다. 나노메디컬 동
기들 중 이제 제가 마지막으로 졸업을 하게 되었네요. 모두 고생하셨고 감사합니
다. 
실험실 생활 중 유일한 동갑이었던 몸짱 효준이, 형 같은 동생 욱진이, 왈가닥 
아가씨 유리, 항상 침착한 어른아이 의덩이, 항상 파이팅 넘치는 야롱이, 웃음과 
애교담당 한슬이, 바쁜데도 항상 묵묵히 나와 같은 길을 함께해준 경배, 이젠 아
기 아빠가 되어 나보다 어른이 되어버린 준혁이, 캐나다인으로 제 2의 인생을 시
작한 바리, 대학원생의 모범의 모습을 보여주는 상준이, 수정샘, 미생물학 교실 
최강미남 창모, 용근이 덕분에 잊지 못할 정도로 많은 추억을 쌓게 되었습니다. 
이후에도 항상 도움이 되는 사람이 되기 위해 노력하겠습니다. 
이젠 어느새 20년이 되어버린 내 삶의 반떵이들 수한, 정봉, 형식, 광현, 선숙, 
화영, 승민, 성환이 10년은 함께해온 위니누나, 레이나누나, 폴형, 현모형, 소리 덕
분에 항상 버틸 수 있었던 것 같습니다. 
마지막으로 지금까지 제가 있을 수 있게 해주신 부모님, 누나, 매형까지 항상 
칭얼대고, 투정만 부렸는데 어느새 이렇게 졸업까지 하게 되었네요. 말은 항상 더 
잘하겠다고 하지만, 항상 최선을 다해 살도록 노력하겠습니다. 감사합니다. 
 
이하 모든 분들에게 감사 드리며 김승재 드림. 
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ABSTRACT 
 
Immunostimulatory Effects of Silver Nanoparticles in 
Immune Cells and their Relevance to Atopic Dermatitis 
 
SeungJae Kim 
 
Graduate Program for Nanomedical Science 
The Graduate School Yonsei University 
 
(Directed by Professor In-Hong Choi) 
 
 
Engineered nanomaterials (NMs) are increasingly used in numerous consumer 
products and biomedical applications that affect humans directly and indirectly. 
However, in vitro and in vivo studies have revealed that nanomaterials can result in 
toxicity. The immunostimulatory effect of silver nanoparticles (AgNPs) is dependent 
on particle size and the production of reactive oxygen species (ROS).  Although these 
products have many opportunities to contact with the skin, the toxicity of AgNPs has 
not been clearly defined. 
Mast cells are potent effectors of the allergic response . They play an important 
role in asthma, atopic dermatitis (AD) and other allergic reactions. In this study, 
RBL2H3 mast cell viability was dependent on the particles size. Granule release, Ca2+  
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influx, the production of hydrogen peroxide and superoxide  and mitochondrial 
membrane damage were used to evaluate cytotoxicity of AgNPs. To evaluate the 
synergistic effect of AgNPs on the induction of allergic reactions in animals, NC/Nga 
mice were used in this study.  NC/Nga mice spontaneously develop an eczematous 
AD-like skin lesion when kept under conventional conditions, but not when maintained 
under specific pathogen-free (SPF) conditions. They are considered an appropriate  
animal model for AD. 
Macrophages are active phagocytic cells present in many tissues . The 
internalization of nanoparticles by phagocytic cells can occur through 
phagocytosis/macropinocytosis, receptor-mediated endocytosis and passive 
penetration. Phagocytosis and macropinocytosis are mediated by actin polymerization, 
which causes cell membrane ruffling.  The process is inhibited by cytochalasin D. 
Endocytosis can occur as clathrin-dependent endocytosis and caveolae-dependent 
endocytosis. Clathrin-dependent endocytosis is inhibited by chlorpromazine, a 
cationic amphiphilic drug that prevents the recycling of clathrin. Caveolae-dependent 
endocytosis is inhibited by nystatin, an antibiotic and sterol-binding agent that 
removes membrane cholesterol, which is important for maintaining and sealing the 
membrane of caveolae. 
In this study, the ability of AgNPs to evoke allergic immune responses was 
investigated in mast cells and macrophages (in vitro) and atopic animal model (in vivo) 
to assess. Cytotoxicity in mast cells was evaluated using Cell Counting Kit-8 (CCK8). 
Cell death was induced by 5 nm AgNPs, but not by 100 nm AgNPs. Granule release 
was evaluated with the β-hexosaminidase assay. Granule release in RBL2H3 cells was 
induced by 5 nm AgNPs, but not by 100 nm AgNPs. N-acetylcystein (NAC) at 5 mM 
vi 
 
inhibited granule release in RBL2H3 cells. To assess intracellular Ca2+  levels, 
RBL2H3 cells were prestained with Fluo4-AM and then treated with AgNPs in HBSS 
with and without Ca2+ . In both groups with and without Ca2+ , 5 nm AgNPs but not 
100 nm AgNPs increased the fluorescence intensity. To evaluate the effect of 
intracellular Ca2+  levels on granule release, RBL2H3 cells were pretreated with 
thapsigargin and then treated with AgNPs. Thapsigargin inhibited the granule release 
induced by 5 nm AgNPs. In addition, the production of hydrogen peroxide and 
superoxide was assessed by staining RBL2H3 cells with CM-H2DCFDA or MitoSOX, 
respectively. Treatment with 5 nm AgNPs increased the fluorescence intensity of CM-
H2DCFDA and MitoSOX in a dose-dependent manner. In addition, JC-1 staining was 
performed to assess mitochondrial depolarization. JC-1 fluorescence intensity 
decreased in cells treated with 5 nm AgNPs. To investigate the synergistic effect of 
AgNPs on the induction of AD, ear thickness was measured once a week and the 
severity score of the AD-like skin lesions was evaluated once a week. Ear swelling 
was more severe in mice treated with 5 nm AgNPs + Ad Biostir when compared with 
that in the AD control group. The severity score of the skin also increased in mice 
treated with 5 nm AgNPs. Epidermal thickness in the group treated with 5 nm AgNPs 
+ Ad Biostir was thicker when compared to that of the Ad Biostir-only group. The 
number of infiltrated mast cells in skin lesions was higher in the group treated with 5 
nm AgNPs + Ad Biostir than in the Ad Biostir-only group. Total IgE levels in the 
serum increased in the group treated with 5 nm AgNPs + Ad Biostir.  
The viability of U937 cells declined abruptly when cells were treated with 5 nm 
AgNPs. The effects of AgNP endocytosis or phagocytosis on cell death were  then 
evaluated. After treatment of U937 cells with AgNPs, neither chlorpromazine, 
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cytochalasin D, nor nystatin prevented cell death. At relatively high concentrations, 
chlorpromazine, cytochalasin D and nystatin partially inhibited the production of I L-8 
following exposure to AgNPs. These findings were confirmed with real- time RT-PCR 
assays. 
Collectively, it was suggested that these immunostimulatory effects has 
contributed to causing AD. These inflammatory effects should be considered and 
evaluated in addition to cytotoxicity when studying the effects of AgNPs exposure in 
human physiology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Silver nanoparticles, Mast cells, Macrophages, ROS, Ca2+, Cytotoxicity, Allergy 
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ABBREVIATIONS 
 
AD   Atopic dermatitis 
AgNPs   Silver nanoparticles 
CCK8   Cell counting kit-8 
cDNA   Complementary DNA 
DLS   Dynamic light scattering 
DNA   Deoxyribose nucleic acid 
ELISA   Enzyme-linked immunosorbent assay 
ER   Endoplasmic reticulum 
FBS   Fetal bovine serum 
HBSS   Hank’s balanced salt solution 
HDM   House dust mite 
H&E   Hematoxylin and eosin 
IL   Interleukin 
IgE   Immunoglobulin E 
LTs   Leukotrienes 
MEM   Minimum essential medium 
NAC   N-acetyl-1-cysteine 
NMs   Engineered nanomaterials 
OD   Optical density 
PBS   Phosphate buffered saline 
PGD2   Prostaglandin D2 
p-NAG  P-nitrophenyl N-acetyl- -D-glucosamide 
PVP   Polyvinylpyrrolidone 
RBL2H3 cell  Rat basophilic leukemia cell line 
RNA   Ribonucleic acid 
ROS   Reactive oxygen species 
RT-PCR Real- time reverse transcription polymerase chain reaction 
SDS Sodium dodecyl sulfate 
SPF Specific pathogen-free 
TEM   Transmission electron microscopy 
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I. Effects of silver nanoparticles in mast cells  
and an atopic mouse model 
 
1. Introduction 
 
Engineered nanomaterials (NMs) are increasingly used in consumer products and 
biomedical applications that affect to humans directly and indirectly (1-5). However, 
in v itro and in v ivo studies have revealed that NMs can result in toxicity. When 
individuals are exposed to nanoparticles, the nanoparticles translocate from the entry 
site into the blood and enter the systemic circulation (6), where they are detected and 
internalized by macrophages or monocytes (7, 8). The physical and chemical 
properties (e.g., size, shape, surface chemistry, composition and aggregation) of NMs 
are known to induce toxic effects. Silver nanoparticles (AgNPs) induce significant 
toxicity in NMs (4). The immunostimulatory effect of AgNPs depends on particle size 
and the production of reactive oxygen species (ROS) (9). The antibacterial activity of 
AgNPs, has been employed in many products (e.g., wound dressings, biofilms and 
dental carriers) (10). Although these products have many opportunities to contact the 
skin, the toxicity of AgNPs has not been clearly defined.  
Mast cells are potent effectors of the allergic response . They play an important role 
in asthma, atopic dermatitis (AD) and other allergic reactions. MC activation occurs 
through the cross- linking of an antigen with two IgE molecules bound to FcεRI, 
leading to the release of mediators. These mediators induce allergic skin inflammation 
(11). Upon stimulation, mast cells release a variety of preformed and newly 
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synthesized inflammatory mediators, including histamine, IL-4, IL-5, IL-6 and tumor 
necrosis factor-α  (TNF-  α). In addition, proteinases (tryptase, chymase and 
carboxypeptidase) and newly generated lipid mediators such as prostaglandin (PGD2), 
leukotrienes (LTs) and platelet-activating factor are released (12). The binding of IP3 
to specific receptors in the endoplasmic reticulum (ER) results in the depletion of Ca2+  
stores, which activates store-operated Ca2+  entry from the extracellular medium. Btk, 
SLP-76, LAT and PLC-γ are essential for generating signals for sustained Ca 2+  influx. 
Ca2+  influx leads to granules exocytosis and the generation of LTs and cytokines (13). 
The activated mast cells release chemical mediators, such as histamine, LTs and 
PGD2. These mediators lead to immediate phase reactions in the tissue, such as 
redness and itching, shortly after allergen-IgE binding. In the later phases of the 
disease, IL-4 and IL-13 are generated and released several hours after allergen-
antibody cross- linking (14). 
AD is a common chronic or chronically relapsing, noncontagious and pruritic 
inflammatory skin disorder (15). AD has various causes, including the abnormal 
activation of immunological and inflammatory pathways resulting in a defective skin 
barrier, exposure to environmental agents and neuropsychological factors (16, 17, 18). 
Approximately 70%-80% of AD patients present with the “extrinsic” form of AD. 
They have elevated serum IgE levels and IgE antibodies to environmental and/or food 
allergens. The remaining 20%–30% present with the “intrinsic” form of AD , with low 
serum IgE levels and no evidence of IgE antibodies (19). The clinical features of AD 
include erythema, edema, vesiculation, crusting, dryness, scaling, excoriations and 
lichenification. Itching is a chief symptom and can be very troublesome  (20). 
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To evaluate the synergistic effect of AgNPs on the induction of allergic reactions in 
animals, NC/Nga mice were used in this study.  The NC/Nga mice were generated 
from Japanese fancy mice and were established as an inbred strain in 1957 (21). 
NC/Nga mice spontaneously develop an eczematous AD-like skin lesion when kept 
under conventional conditions, but not when maintained under specific pathogen-free 
(SPF) conditions. They are considered an appropriate animal model for AD (22). 
In this study, the activation of mast cells by silver nanoparticles was investigated in 
mast cells (in v itro) and atopic animal models (in v ivo) to assess the ability of 
AgNPs to evoking allergic immune responses. The results of this study increase our 
understanding of the immunostimulatory effect of AgNPs, particularly in allergic 
diseases. 
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2. Materials and Methods  
 
2.1. AgNPs  
AgNPs in an aqueous suspension were provided by I&C (5 nm; Seoul, Korea) or 
purchased from ABC Nanotech (100 nm; Daejeon, Korea). Briefly, AgNPs (5 nm and 
100 nm) were synthesized by the reduction of Ag(NO 3). All AgNPs were round and 
polyvinylpyrrolidone (PVP)-coated. Endotoxin contamination tests using the 
PyroGene recombinant factor C assay (Cambrex Bioscience, Walkersville, MD, 
USA.) were negative (endotoxin <0.01 U/mL). For cell culture, different 
concentrations of AgNPs were prepared in minimum essential medium (MEM) with 2 
mM L-glutamine supplemented with 10% fetal bovine serum (FBS), 100 U/mL 
penicillin and 100 U/mL streptomycin.  
 
2.2. Characterization of AgNPs  
The diameter was determined with transmission electron microscopy (TEM, model 
JEM-1011, JEOL, Tokyo, Japan). Agglomeration of the nanoparticles in MEM with 
10% FBS at 1, 5 and 15 μg/mL was analyzed using dynamic light scattering (DLS) 
(Malvern Instruments, Novato, CA, USA.). 
 
2.3. Ce ll culture  
The RBL2H3 rat mast cells (ATCC, Manassas, VA, USA.) were cultured in MEM 
containing 10% FBS at 37°C in a moisturized 5% CO 2 incubator. Although endotoxin 
was not detected in the AgNPs used in this study, polymyxin B (InvivoGen, San Diego, 
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CA, USA.) at a concentration of 10 ng/mL was added as an endotoxin neutralizer. 
The culture medium was changed every 2-3 days to maintain a cell density of 
approximately 2 ×  106 cells/mL. 
 
2.4. Cytotoxicity assay 
Cell viability was assessed using the Colorimetric Cell counting Kit-8 (CCK-8) 
(Dojindo Laboratories, Kyoto, Japan). CCK -8 is a colorimetric assay that uses a 
highly water-soluble tetrazolium salt, WST-8[2-(2-methoxy-4-nitrophenyl)-3-(4-
nitrophenyl)-5- (2,4-disulfophenyl)- 2H-tetrazolium, monosodium salt]. Cells were 
plated in 24-well plates at 4 ×  105 cells in 500 μL of MEM supplemented with 10% 
FBS and incubated overnight in a 5% CO 2 incubator. The medium was then removed 
and the cells were washed twice with Hank’s balanced salt solution (HBSS). The cells 
were then treated with 400 µL/mL of AgNP solution diluted in MEM supplemented 
with 10% FBS. After 24 hr, 15 µL of CCK-8 reagent was added to each well and 
incubated at 37°C for 2 hr. After centrifugation, 100 μL of supernatant was 
transferred to 96-well microtiter plates and the optical density (OD) was measured at 
450 nm. As pretreatment, NAC (SigmaeAldrich, St. Louis, MO, USA) at 5-10 mM 
was added for 30 min before the treatment with AgNPs. 
 
2.5. Granule  re lease  assay 
Cells were plated at a density 4 ×  105 cells in 24-well plates in 500 μL of MEM 
supplemented with 10% FBS and incubated in a 5% CO 2 incubator. After overnight 
incubation, the medium was removed and the cells were washed with HBSS. The cells 
were then treated with 200 µL of AgNP solution diluted in HBSS.  -Hexosaminidase 
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release from RBL2H3 cells was measured by incubating 25 μL of the supernatant or 
lysed cell pellet with 5% Triton X-100 in 25 μL of p-nitrophenyl N-acetyl- -D-
glucosamide (p-NAG) in a 96-well plate (Nunc, Roskilde, Denmark) for 2 hr at 37°C. 
The reaction was stopped by the addition 250 μL of 0.2 M glycine (pH = 10.6) and 
the OD was read at 405 nm. 
 
2.6. Assay for total ROS and mitochondrial superoxide  
After treatment with AgNPs for 30 min, cells in HBSS were stained with 2 μM 
CM-H2DCFA (Invitrogen, Carlsbad, CA, USA) for 30 min to detect reactive 
hydrogen peroxide and 2 μM MitoSOX (Invitrogen) for 15 min to detect 
mitochondrial superoxide. Staining was performed at 37°C in the dark. Cells were 
stained with 2 μM of JC-1 (Invitrogen) to assess mitochondrial depolarization. The 
OD was detected using a VICTOR X4 multi label plate reader (Perkin-Elmer, 
Norwalk, CT, USA.) at 580 nm for CM-H2DCFA or 510 nm for MitoSOX. 
 
2.7. Assay for mitochondrial membrane  integrity 
After treatment with AgNPs for 30 min, cells were stained with 2 μM of JC-1 
(Invitrogen) for 15 min at 37°C  in the dark. The OD was read at 590 nm using a 
VICTOR X4 multi label plate reader (Perkin-Elmer). 
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2.8. Ca2+  influx assay 
Cells were stained with Fluo4-AM (Invitrogen) for 30 min and diluted in HBSS at 
37°C in the dark. After treatment with fluorescent dyes, Cells were treated with 
AgNPs. After treatment with nanoparticles, cells were monitored using a Victor X4 
multi label plate reader (Perkin-Elmer) at a constant temperature of 36°C and 
measured every 5 sec for 600 sec.
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2.9. Atopic animal mode l and induction of AD 
Six-week-old female NC/Nga mice weighing 22 ±  2 g were purchased from 
Central Lab. Animal Inc. (Seoul, Korea) and maintained for 1 week before 
experiments. All animal experiments were performed in compliance with the guidelines 
of Yonsei University Institutional Animal Care and protocols were reviewed and  
approved by the Institutional Animal Care and Use  Committees of the Laboratory 
Animal Research Center at Yonsei University Health System (Permit Number: 2013 -
0176-2). All mice were maintained in the SPF facility of the Yonsei Laboratory 
Animal Research Center. 
To induce AD, the hair on the back was shaved with depilatory cream (Veet, Oxy 
Reckitt Benckiser Ltd. Slough, USA) 1 day before experiments. For barrier 
disruption, 150 μL of 4% (w/v) sodium dodecyl sulfate (SDS) was applied to the 
shaved dorsal skin and ear skin. After 2 hr, 100 μL of AgNPs was added to the same 
regions and left for 2 hr. Thereafter 100 mg of Ad Biostir (Biostir, Kobe, Japan) was 
applied. Ad Biostir prepared from house dust mites, a crude extract allergen of 
Dermatophagoides farina (21). The skin treatment was performed twice a week for 8 
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weeks. The mice (n = 12) were allocated to four groups (3 mice/group): Ad Biostir-
only group (100 μL distilled water + Ad Biostir), 5 nm AgNP 40 μg/mL group (100 
μL of 5 nm AgNPs at 40 μg/mL + Ad Biostir), 5 nm AgNP 400 μg/mL group (100 
μL of 5 nm AgNPs at 400 μg/mL + Biostir-AD) and 5 nm AgNP 4,000 μg/mL group 
(100 μL of 5 nm AgNPs at 4,000μg/mL + Ad Biostir). 
 
2.10. Measurement of clinical skin score  
The clinical skin score is the sum of individual scores graded as 0 (absence), 1 
(mild), 2 (moderate) and 3 (severe) for each of four signs and symptoms 
(erythema/hemorrhage, scaling/dryness, edema and excoriation/erosion). 
 
2.11. His topathological analys is  
AD-like skin lesions were selected and 2  mm punch biopsies were performed for 
immunohistochemistry. Skin lesions were fixed with 10% neutral formalin, embedded 
in paraffin and sectioned to a depth of 10 μm. To detect the epidermal thickness and 
infiltration of inflammatory cells, sections were stained with hematoxylin–eosin (H&E). 
Toluidine blue staining was performed to count the number of mast cells. All stained 
sections were observed under a microscope with twin CCD cameras (magnification, 
×100, × 400; Olympus, Tokyo, Japan). 
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2.12. Detection of total IgE in the  serum 
Blood samples (100 μL) were collected from the retro orbital plexus every week 
and the serum was separated by centrifugation at 2,000 rpm for 5 min and stored at -
20°C until use. The serum IgE levels were analyzed using the mouse IgE ELISA kit 
(432402; Biolegend, San Diego, CA, USA.). The microplates (Nalgen; Nunc 
International, Naperville, IL, USA) were coated with coating buffer and IgE capture 
antibody overnight at 4°C and then blocked with 10% FBS in phosphate-buffered 
saline (PBS) for 1 hr at room temperature. Serially diluted serum samples (1:100-
1:1,000) were added and incubated for 2 hr at room temperature. The plates were 
then washed with PBS plus 0.05% Tween 20, Incubated for 2 hr with horseradish 
peroxidase–conjugated rat anti-mouse IgE antibodies and washed with again PBS plus 
0.05% Tween 20. The color reaction was developed with 3, 3′, 5, 5′-
tetramethylbenzidine and stopped with 1 N H2SO4. The absorbance was read at 450 
nm with a microplate reader.  IgE levels were determined by comparing the OD values 
of the study groups to the OD values of standard IgE. 
 
2.13. Statis tical analys is  
Data were expressed as the mean ±  SD. The statistical comparisons were 
performed using Student’s t- test for two groups and ANOVA with Bonferroni post-
tests for more than two groups. Statistical analyses were performed using GraphPad 
Prism 5. A p-value of less than 0.05 was considered significant. 
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3. Results 
 
3.1. Characterization of AgNPs  
In TEM images, the AgNPs (5 nm and 100 nm) were relatively uniform in size (Fig. 
1A). DLS analysis by number showed that the mean size was 5.1 nm for the 5 nm 
AgNPs and 74.2 nm for the 100 nm particles (Fig. 1B). 
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Figure  1. Characte rization of AgNPs . (A) TEM images of AgNPs showed that the  5 
nm and 100 nm particles were relatively uniform in size. (B) DLS analysis by number 
showed that the mean size was 5.1 nm for the 5 nm AgNPs and 74.2 nm for  the 100 nm 
AgNPs. For DLS analysis .  AgNPs were dispersed in MEM conta ining 10% FBS.  
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3.2. Cytotoxicity in mast ce lls  
As shown in Fig. 2, cell death was induced by 5 nm AgNPs starting at 1.2 μ g/mL, 
but not by 100 nm AgNPs. The LC 50 of the 5 nm AgNPs was 1.96 μg/mL. Cell death 
was not induced by 100 nm AgNPs at concentrations up to 4 μg/mL. Therefore, 
cytotoxicity was dependent on the particle size. Cell death was completely inhibited 
by NAC at 5 mM. 
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Figure  2. Cytotoxicity of AgNPs  in mas t ce lls .  RBL2H3 cells were treated with 5 
nm or 100 nm AgNPs for 24 hr, and cytotoxicity was determined with the  CCK-8 assay.  
Cells were treated with NAC for 30 min before treatment with AgNPs.  The LC50 of the 
5 nm AgNPs was approximately 1.96 μg/mL. Data represent the mean ± SD. ***p < 
0.001. 
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3.3. Granule  re lease  in mast ce lls  
Granule release of 18.9%-76.9% in RBL2H3 cells was induced by 0.15 μg/mL-0.6 
μg/mL of 5 nm AgNPs, but not by 100 nm AgNPs. Phorbol 12-myristate 13-acetate 
(PMA)/ionomycin was used as a positive control of to induce granule release (Fig. 
3A). Granule release in RBL2H3 cells was inhibited by NAC at 5 mM (Fig. 3B). 
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Figure  3. Granule  re le as e  by AgNPs  in mas t ce lls .  (A) RBL2H3 cells were treated 
with 5 nm AgNPs for 30 min, and granule release was determined with the  β-
hexosaminidase assay. (B) Cells were treated with NAC for 30 min before treatment 
with AgNPs. Data represent the mean ± SD. ***p < 0.001.  
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3.4. Calcium influx in mast ce lls  and inhibition by thaps igargin 
To assess intracellular Ca2+  levels, RBL2H3 cells were pre-stained with Fluo4-AM 
and then treated with AgNPs in HBSS with Ca 2+  (Fig. 4A) or HBSS without Ca2+  
(Fig. 4B). Treatment with 5 nm AgNPs at 2 µg/mL increased the fluorescence 
intensity in both groups with Ca2+ , 0.65-fold at 600 sec), without Ca2+ , 0.53-fold at 
600 sec). Treatment with 100 nm AgNPs had no effect.  
To evaluate the effect of intracellular Ca 2+  levels on granule release, RBL2H3 cells 
were pretreated with thapsigargin and then treated with AgNPs. Thapsigargin was 
used to deplete the intracellular Ca2+  stores. Granule release induced by 5 nm AgNPs 
deceased from 75% without thapsigargin to 37% with thapsigargin. 
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Figure  4. De te ction of intrace llular Ca2+  le ve ls .  RBL2H3 cells were pre -stained 
with Fluo4-AM for 30 min and then treated with AgNPs. Cells were monitored using a 
Victor X4 multi label plate reader and measured every 5 sec. (A) HBSS with Ca2+ , (B) 
HBSS without Ca2+ .  
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Figure  5. Inhibition of granule  re le as e  by thaps igargin.  RBL2H3 cells were pre-
treated with thapsigargin for 30 min and then treated with 5 nm AgNPs. Granule 
release was determined using the  β-hexosaminidase assay. Data represent the mean ± 
SD. ***p < 0.001.  
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3.5. Generation of total ROS and mitochondrial superoxide  in mast ce lls  
As shown in Fig. 6, the production of hydrogen peroxide and superoxide was 
assessed by staining RBL2H3 cells with CM-H2DCFDA and MitoSOX, respectively. 
Treatment with 5 nm AgNPs increased the production of total ROS, including 
hydrogen peroxide and superoxide, in a dose-dependent manner. Treatment with 4 
µg/mL AgNPs increased ROS production 4.9-fold when compared with control (Fig. 
6A). Mitochondrial superoxide also increased in a dose-dependent manner after 5 nm 
AgNPs treatment with 4 µg/mL AgNPs increased superoxide levels 2-fold when 
compared with control (Fig. 6B). Total ROS and mitochondrial superoxide were not 
affected by treatment with 100 nm AgNPs. 
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Figure  6. Ge ne ration of total ROS and mitochondrial s upe roxide .  RBL2H3 cells 
were treated with AgNPs for 30 min. (A) Cells were stained with CM-H2DCFDA for 
30 min. (B) Cells were stained with MitoSOX for 15 min. The fluorescence intensity 
was analyzed using a  Victor X4 multi label plate reader. Data represent t he mean ± SD. 
***p < 0.001.
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3.6. Assessment of mitochondrial membrane  integrity  
Mitochondrial membrane integrity was assessed by staining cells with JC-1, a 
lipophilic cation used to measure mitochondrial membrane potential. The JC -1 
fluorescence intensity increased 4.1-fold over that in control cells when cells were 
treated with 5 nm AgNPs at 4 µg/mL. The effect was dose-dependent. However, 100 
nm AgNPs at concentrations up to 4 g/mL did not increase the JC-1 fluorescence 
intensity (Fig. 7). 
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Figure  7. Mitochondrial me mbrane  inte grity.  RBL2H3 cells were treated with 5 nm 
and 100 nm AgNPs for 1 hr. JC-1 staining was performed to evaluate disturbance s in 
the mitochondrial membranes. Data represent the mean ± SD. ***p < 0.001.  
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3.7. Clinical features  of skin le s ions  in AD mice  
To investigate the synergistic effect of AgNPs on the induction of AD, ear 
thickness was measured once a week, and the severity score of the AD-like skin 
lesions was evaluated once a week. Ear swelling was more severe in mice treated with 
4,000 µg/mL 5 nm AgNPs and Ad Biostir (0.78 mm at 3 weeks) than in AD control 
mice (0.4 mm at 3 weeks) (Fig. 8). In addition, the severity score was higher in mice 
treated with 4,000 µg/mL 5 nm AgNPs (7 points at 3 weeks) than in AD control mice 
(2 points at 3 weeks) (Fig. 9). 
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Figure  8. Ear s we lling in AD mice .  Ear thickness was measured using a dial 
micrometer.  Data represent the mean ± SD. N=3. 
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Figure  9. Clinical s e ve rity s core  of s k in le s ions  in AD mice .  The score is obtained 
by grading four signs (erythema/hemorrhage, scaling/dryness , edema, 
excoriation/erosion), each on a scale of 0 (absent), 1 (mild), 2 (moderate), or 3 (severe) . 
Data represent the mean ± SD. N = 3. 
27 
 
3.8. His topathological findings  in skin le s ions  of AD mice  
Two week samples were used for H&E and toluidine blue staining. The epidermal 
thickness of the group treated with 5 nm AgNPs + Ad Biostir was thicker (116 ±  
14.6 µ m) than that of the Ad Biostir-only group (49 ±  9.5 µm) (Fig. 10D). Mast cell 
numbers in four high-power fields at ×400 magnification were selected randomly and 
counted. The number of infiltrated mast cells in the skin lesions was higher in the 
group treated with 5 nm AgNPs + Ad Biostir (23 ±  4.9) than in the Ad Biostir-only 
group (6 ±  2.3) (Fig. 11D). 
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Figure  10. His tological fe ature s  of the  s kin le s ions  in AD mice .  (A-C) The dorsal 
skin was stained with H&E. (D) The epidermis thickness of five regions in each group 
was measured using a microscope (×100).  Data represent the mean ± SD. ***p < 0.001, 
**p < 0.05.  
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Figure  11. Numbe r of mas t ce lls  in the  s kin le s ions  of AD mice .  (A-C) The dorsal 
skin was stained with toluidine blue. The number of mast cells/unit area of dermis in 
four sites chosen at random was counted (×400) (D).  
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3.9. Total serum IgE leve ls  in AD mice  
Total IgE levels in the serum were higher in the group treated with 5 nm AgNPs + Ad 
Biostir (510 ng/mL at 2 weeks) than in the control group (Fig 12). IgE was not 
detectable in the control group (Ad Biostir-only group) or the 100 nm AgNPs. 
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Figure  12. IgE le ve ls  in the  s e rum of AD mice .  The amount of serum IgE was 
analyzed using a mouse IgE-specific ELISA Kit. Sample s were diluted 1:100 and 
1:1,000. Data represent the mean ± SD.  N = 3.  
32 
 
4. Discussion 
 
The cardinal pathway of granule release is induced by the attachment of IgE-bound 
allergens to high-affinity FcεRI receptors on mast cells and the crosslinking of IgE 
molecules by allergens. These events lead to a complex cascade of intracellular Ca 2+  
signaling (24), which is an essential mechanism for degranulation in mast cells. In this 
study, it was investigated that whether AgNPs could induce degranulation in mast cells 
in the absence of IgE crosslinking by allergens. Our data showed that AgNPs induced 
cytotoxicity and granule release in RBL2H3 mast cells  without IgE crosslinking by 
allergens (Fig. 2 and 3). ROS production was the main toxicity mechanism induced 
AgNPs (9, 29). Cytotoxicity and granule release were inhibited by the ROS scavenger 
NAC, indicating that induction of ROS by AgNPs is an important cause of 
cytotoxicity and granule release.  Ca2+  influx, the main upstream event in degranulation, 
was induced in RBL2H3 cells treated with 5 nm AgNPs in buffer with or without Ca2+  
(Fig. 4). These results indicated that Ca2+  influx depended on intracellular Ca2+  stores. 
A recent report has shown that TiO 2 nanoparticles can induce calcium influx in mast 
cells via an ER-dependent IP3-IP3 receptor pathway (25). Calcium influx was 
induced by silica nanoparticles in monocytes (26). In addition, Ca2+  influx induced by 
TiO2 and silica nanoparticles is associated with intracellular Ca2+  and granule release. 
The ER is the main source of intracellular Ca2+  (27). To confirm that the ER was 
the source of the intracellular Ca2+  stores, we used thapsigargin, a known inhibitor of 
the ER calcium ATPase. Granule release in RBL2H3 cells treated with 5 nm AgNPs 
was inhibited by thapsigargin (Fig. 5). This result indicated that AgNPs activated the 
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ER calcium ATPase to induce intracellular Ca2+  influx and granule release in RBL2H3 
cells. 
ROS are chemically reactive molecules that contain oxygen. ROS are produced 
intracellularly via multiple mechanisms depending on the cell and tissue type. The 
major sources of ROS are the NADPH oxidase complexes in the cell membrane, ER, 
peroxisomes, and mitochondria (28). AgNPs reduce the ATP content, causing damage 
to mitochondria and increasing the production of ROS in a dose-dependent manner. 
(29). A recent report has shown that calcium release is related to mitochondrial 
disruption and ROS (30). In this study, hydrogen peroxide and mitochondrial 
superoxide were induced in RBL2H3 cell treated with 5 nm AgNPs (Fig. 6). 
Mitochondrial damage was induced in RBL2H3 cells treated with 5 nm AgNPs (Fig. 
7). These results suggest that hydrogen peroxide and mitochondrial superoxide 
induced mitochondrial damage mitochondrial damage, which would cause ER stress 
and Ca2+  influx. 
This study demonstrated that 5 nm AgNPs induced granule release in RBL2H3 cells 
without the crosslinking of IgE molecules. Ca2+  influx via the ER and ROS production 
by the mitochondria were the main cause. Granule release, Ca2+ influx, and ROS 
production were not observed after treatment with 100 nm AgNPs. 
In this study, the effect of AgNPs on AD was examined using NC/Nga mice.  
Research related to dermal AgNP exposure is mainly restricted to determining the 
efficacy of wound dressings (31, 32). However, with dermal exposure, it is possible 
that AgNPs induce immunostimulatory effects. Immunostimulatory effects induced by 
AgNPs depend on the skin being damaged (33). A recent report showed that 10 nm 
AgNPs did not induce severe toxic effects in rats up to 2,000 mg/kg (34). However, 
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our results showed that AgNPs induced immunostimulatory effects in NC/Nga mice. 
Ear swelling was induced in NC/Nga mice treated with 5 nm AgNPs (Fig. 8). Ear 
swelling is one of the major inflammatory responses. The response was induced by 
AgNPs in a dose-dependent manner. Mice treated with 5 nm AgNPs had a high score 
after 2 weeks (Fig. 9). Some wounds in these mice were a result of scratching 
behavior. A main feature of AD is dry itchy skin.  Intense pruritus and the resulting 
scratching cause continuous mechanical skin injury that leads to cytokine and 
chemokine release in the skin. This leads to a further increase in skin permeability that 
promotes the entry of allergens in the skin (35). Scratching behavior of normally 
occurs at 6-8 weeks in NC/Nga mice induced with the house dust mite (HDM). It is 
the first sign of skin changes. Scratching behavior is followed by rapidly developing 
erythematous, erosive lesions with edema and hemorrhage on the skin (21). Our 
results indicated that the immunostimulatory effects induced by AgNPs could rapidly 
lead to atopic symptoms in NC/Nga mice. Furthermore, the histological features of 
the skin lesions also confirmed AD. The epidermis was thicker in the skin lesions of 
mice exposed to 5 nm AgNPs (Fig. 10). This indicates that inflammation occurs in 
lesions treated with AgNPs. Infiltration of mononuclear cells was observed the skin 
lesions of mice treated with 5 nm AgNPs. Mast cell numbers increased when mice 
were treated with 5 nm AgNPs. (Fig. 11). The histological features of mice treated 
with 5 nm AgNPs were consistent with atopic symptoms. 
Pathologically, AD is associated with an IgE-  mediated hypersensitivity reaction. In 
this study, the total serum IgE level increased in NC/Nga mice treated with 5 nm 
AgNPs (Fig. 12). Humans with AD have high levels of IgE antibodies to HDM and 
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other allergens. High levels of IgE can lead to improvements in AD The pathological 
features of mice treated with 5 nm AgNPs were consistent with atopic symptoms. 
In conclusion, this study showed that AgNPs could aggravate skin symptoms at the 
early stages of AD in NC/Nga mice.  AgNPs induced immunostimulatory effects, such 
as activation of mast cells via mitochondrial ROS. I suggest that these 
immunostimulatory effects contribute the development of AD. In recent years, 
nanotoxicity has been widely studied.  However, the research related to direct 
pathogenic diseases such as AD is insufficient. Our results demonstrate that AgNPs 
have a synergistic effect on diseases such as AD.  Inflammatory effect should be 
considered and evaluated along with cytotoxicity when studying the effects of AgNP 
exposure on human physiology. 
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II. Effects of silver nanoparticles in macrophages 
 
1. Introduction 
 
The dramatic increase in human exposure to nanomaterials has raised concerns 
regarding their potentially harmful effects on cells (36). From entry sites, such as the 
skin or respiratory tract, nanoparticles can translocate to other parts of the body ( 37, 
38). Macrophages are active phagocytic cells present in many tissues as resident 
macrophages, such as alveolar macrophages in the lungs or skin macrophages. The 
internalization of nanoparticles by phagocytic cells can occur through 
phagocytosis/macropinocytosis, receptor-mediated endocytosis and passive 
penetration (39, 40). Phagocytosis and macropinocytosis are mediated by actin 
polymerization, which causes cell membrane ruffling. The processes inhibited by 
cytochalasin D (41). Endocytosis can occur as clathrin-dependent endocytosis and 
caveolae-dependent endocytosis (42). Clathrin-dependent endocytosis is inhibited by 
chlorpromazine, a cationic amphiphilic drug that prevents the recycling of clathrin (43). 
Caveolae-dependent endocytosis is inhibited by nystatin (44), an antibiotic and sterol-
binding agent that removes membrane cholesterol, which is important for maintaining 
and sealing the plasma membranes of caveolae (45). 
This study was conducted to determine which internalization mechanisms are 
important for cellular uptake and cellular activation following exposure of 
macrophages to 5 nm AgNPs. Macrophages were treated with AgNPs at a 
concentration that does not induce cell death, and IL-8 production was examined. The 
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results improve our understanding of the effect of AgNPs on macrophages during the 
induction of immune responses and inflammation. 
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2. Materials and Methods  
 
2.1. Chemicals  
The AgNPs were used the 5 nm AgNPs described on page 4. For cell culture, 
AgNPs were prepared in RPMI 1640 medium with 2 mM L-glutamine, 10% FBS, and 
penicillin and streptomycin (100 U/mL each). U937 cells were treated for 1 hr with 
chlorpromazine (C8183; Sigma, St. Louis, MO, USA.), cytochalasin D (C8273; 
Sigma), or nystatin (N6261; Sigma) at the indicated concentrations before the 
addition of nanoparticles. At the concentrations used in this study, the inhibitors were 
not toxic to U937 cells.  
 
2.2. Ce ll culture  and cytotoxicity assay 
The human macrophage cell line U937 was cultured in RPMI 1640 containing 10% 
FBS and streptomycin and penicillin (100 U/mL each) at 37°C in a humidified 5% 
CO2 incubator. Polymyxin B (InvivoGen, San Diego, CA, USA) was added as 
described at page 4. Cell viability was assessed using CCK -8 as described on page 5. 
 
2.3. ELISA 
To assess the IL-8 concentration in the cell culture supernatants, an enzyme-linked 
immunosorbent assay (ELISA) was performed using human cytokine IL-8 assay kits 
(BD Biosciences, San Jose, CA, USA.). The optical densities were measured with a 
microplate reader at 450 nm. 
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2.4. Real-time  RT-PCR 
cDNA was synthesized from total RNA via reverse transcription with oligo-dT 
primers (Invitrogen). Primer pairs designed to amplify the cDNA encoding IL-8 were 
prepared using the Universal Probe Library Assay Design Center (Roche Applied 
Science, Indianapolis, IN, USA.). The primer sequences for IL-8 were as follows: 
forward, 5’-GTG CAG TTT TGC CAA GGA GT-3’ and reverse, 5’-CTC TGC ACC 
CAG TTT TCC TT-3’. PCR reactions were performed using FastStart DNA Master 
SYBR Green I reagents and 3 mM MgCl2 according to the manufacturer’s instructions 
(Roche Applied Science) with a 7500 Real-Time PCR system (Applied Biosystems, 
Foster City, CA, USA.). The PCR cycle parameters were: 2 min at 50°C, 10 min at 
95°C and 40 cycles of 95°C for 10 sec and 59°C for 1 min. Real- time RT-PCR data 
for each gene product was normalized to the levels of glyceraldehyde 3-phosphate 
dehydrogenase. All transcript levels were reported as the mean ±  SD relative to 
untreated controls from triplicate analyses. One-way analysis of variance was used to 
assess the differences between the control and experimental groups. 
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3. Results  
 
3.1. Cytotoxicity in macrophages  
The viability of U937 cells declined abruptly when the cells were treated with 5 nm 
AgNPs 0 -0.8 μg/mL (Fig. 13A). The LC 50 for the 5 nm AgNPs was 0.36 μg/mL in 
U937 cells. Next, the effects of inhibiting the endocytosis and phagocytosis of AgNPs 
was evaluated. After treatment of U937 cells with 0.5 μg/mL AgNPs, neither 
chlorpromazine, cytochalasin D, nor nystatin prevented cell death (Fig. 13B). 
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Figure  13. Cytotoxicity of AgNPs  in macrophage s .  (A) Cytotoxicity in U937 cells 
was assessed with the  CCK-8 assay. The LC50 of 5 nm AgNPs was 0.36 μg/mL. (B) 
Each inhibitor was added 1 hr before exposure of the cell to 0.5 μg/mL of 5 nm AgNPs. 
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3.2. IL-8 production and the  e ffect of endocytos is /phagocytos is  inhibitors  
As shown in Fig. 14A, relatively high concentrations of chlorpromazine, 
cytochalasin D and nystatin partially inhibited the production of IL-8 by macrophages 
after exposure to AgNPs. These findings were confirmed in real- time RT-PCR assay 
(Fig. 14B).
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Figure  14. Effe cts  of e ndocytos is /phagocytos is  inhibitors  on IL -8 production in 
macrophage s .  Chlorpromazine (12.5 μM), nystatin (40 μg/mL) , and cytochalasin D (20 
μM) were added 1 hr before treatment of the cells with AgNPs. (A) IL-8 levels in the 
culture supernatants were assessed with ELISA 18 hr after treatment with 5 nm AgNPs. 
(B) Total RNA was prepared, and real-time RT-PCR was performed.  
*p < 0.05, †p < 0.001.
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4. Discussion 
 
The results of this study suggest that a large portion of the 5 nm AgNPs enters the 
cell by means other than endocytosis and phagocytosis. One mechanism of entry might 
be direct penetration of the cell membrane, given the extremely small size of the 
nanoparticles. Quantum dots (46, 47) can penetrate cell membranes as can gold 
nanoparticles (48, 49). Gold nanoparticles of 2.4 nm in diameter were found to 
localize in the nucleus via direct penetration, whereas gold nanoparticles 16 nm and 
larger did not enter the cells (49). Therefore, in addition to entering via endocytosis 5 
nm AgNPs might enter cells by penetrating the lipid bilayer in a passive manner. 
Tissue macrophages are distributed throughout the body. They secrete a large pool 
of cytokines when they encounter foreign materials. Among the cytokines that 
participate in innate immunity, IL-8 recruits neutrophils to acute inflammation sites. A 
previous study demonstrated that AgNPs triggered macrophages to release IL-8 (9). 
Therefore, we chose IL-8 as an early responsive indicator for determining when 
macrophages are exposed to AgNPs.  
In this study, a complex mechanism, rather than a dominant mechanism, was found 
to be involved in the cellular uptake of nanoparticles and the production of IL-8 by 
macrophages following exposure to AgNPs. The internalizing of nanoparticles has 
multiple steps. The uptake of quantum dots is dependent on environmental 
temperatures (50), indicating that a dynamic cellular process is involved. Additionally, 
the cellular uptake of quantum dots is dependent on the cell type and cell 
differentiation stage, as demonstrated in dendritic cells. Mature dendritic cells 
stimulated with lipopolysaccharide exhibited increased uptake of quantum dots when 
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compared with unstimulated dendritic cells (51). Our real- time RT-PCR data 
indicated that chlorpromazine inhibited IL-8 production by macrophages treated with 
nanoparticles to a greater extent than did cytochalasin D or nystatin. Therefore, the 
role of the clathrin-dependent endocytosis of nanoparticles in for IL-8 production by 
macrophages might be greater than of caveolin-mediated endocytosis and 
phagocytosis. 
In summary, these results demonstrate that multiple mechanisms, including 
endocytosis and phagocytosis, contribute to IL-8 production in macrophages 
following exposure to 5 nm AgNPs. However, endocytosis or phagocytosis inhibitors 
were did not inhibit the cytotoxicity triggered by these nanoparticles.  
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Conclusion & Summary 
 
In this study, The toxic mechanism of AgNPs in macrophages, mast cells and 
NC/Nga mice was investigated. 
 
1. RBL2H3 mast cell viability was dependent on the particles size. Cell death was 
induced by 5 nm AgNPs. The viability of cells treated with 5 nm and 100 nm AgNPs 
differed. 
 
2. Granule release was induced by 5 nm AgNPs in RBL2H3 mast cells. Treatment 
with N-acetyl-1-cystein (NAC) attenuated cell death and granule release. 
 
3. Ca2+  influx was induced by 5nm AgNPs in HBSS with or without Ca2+ , but not by 
100 nm AgNPs. 
 
4. Thapsigargin inhibited granule release induced by 5 nm AgNPs. At the same dose, 
100 nm AgNPs did not induce granule release.  
 
5. The production of hydrogen peroxide and superoxide increased in a dose -
dependent in cells treated with 5 nm AgNPs. Hydrogen peroxide and superoxide were 
not induced by 100 nm AgNPs. 
 
6. Mitochondrial membrane damage was induced by 5 nm AgNPs, but not by 100 nm 
AgNPs. 
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7. Mouse ear swelling induced in mice treated with 5 nm AgNPs, as did the severity 
score. 
 
8. The epidermis of mice treated with 5 nm AgNPs was thicker than that of control 
mice. The number of infiltrated mast cells in the skin lesions increased. Total serum 
IgE levels also increased in mice treated with 5 nm AgNPs. 
 
9. Multiple mechanisms, including endocytosis and phagocytosis, contribute to IL-8 
production in macrophages following exposure to 5 nm AgNPs. 
 
10. After treatment of U937 cells with 5 nm AgNPs, neither chlorpromazine, 
cytochalasin D, nor nystatin prevented cell death. 
 
These results show that AgNPs can aggravate skin symptoms at the early stages of 
AD in NC/Nga mice. AgNPs induced immunostimulatory effects, including the 
activation of mast cells via mitochondrial ROS. Multiple mechanisms, including 
endocytosis and phagocytosis, contribute to IL-8 production in macrophages 
following exposure to 5 nm AgNPs. These immunostimulatory effects might contribute 
to the development of AD. Thus, inflammatory effects should be considered and 
evaluated along with cytotoxicity when studying the effects of AgNP exposure on 
human physiology. 
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은나노입자의  면역세포  자극  효과와  
아토피  동물  모델에서  아토피  항진  효과  
 
김  승  재  
 
연세대학교  대학원  나노메디컬  협동과정  
 
(지도교수  최  인  홍 ) 
 
제조 나노물질이 다양한 산업 분야에서 이용되면서 인체는 
직∙ 간접적으로 나노물질에 노출되고 있다 . 본 연구에서는 나노물질의 
면역계에 대한 영향을 파악하고자 대표적인 제조 나노물질인 
은나노입자를 이용하여 비만세포와 대식세포 그리고 아토피 동물 
모델을 이용한 연구를 수행하였다 . 
첫째 , 비만세포는 아토피 및 천식 등 알레르기 반응에서 중요한 
면역세포이다 . 5 nm 또는 100 nm 은나노입자가 비만세포 (RBL2H3)를 
활성화시키는지 관찰하기 위하여 세포독성을 유발하지 않는 낮은 
농도의 5 nm 은나노입자를 처리하면 비만세포에서 세포 내 
칼슘이온이 증가하고 , 탈과립 현상이 유도되며 , 더불어 미토콘드리아 
막 손상과 활성산소 생성이 유도되었다 . 그러나 100 nm 은나노입자는 
동일한 농도에서 이러한 현상을 유발하지 않았다 . 
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둘째 , 아토피 동물 모델 마우스 (NC/Nga)에서 은나노입자에 의한 
아토피 항진 작용을 확인하기 위해 집먼지진드기 연고와 은나노입자를 
동시에 피부에 발라주었다 . 귓볼 두께 및 피부 임상 증상을 측정한 
결과 5 nm 은나노입자를 투여한 군에서 귀의 부종이 더 증가하였고 , 
피부 임상 증상도 증가하였다 . 조직학적 소견을 통하여 5 nm 
은나노입자를 투여한 군에서는 표피가 두꺼워지고 진피 내 비만세포의 
수가 증가함을 관찰하였고 , 혈액 총 IgE 양이 증가함을 관찰하였다 . 
100 nm 은나노입자를 투여한 군에서는 이러한 효과가 관찰되지 
않았다 . 이를 통하여 5 nm 은나노입자가 아토피 동물 모델에서 
아토피 증상을 다소 빨리 유도하며 증상도 악화시킴을 확인하였다 . 
셋째 , 대식세포는 선천면역계 세포로서 탐식작용을 통하여 
미생물을 제거하고 염증 cytokine 을 생성하여 선천연역을 항진시킬 뿐 
아니라 항원을 T 림프구로 전달하고 , 적응면역을 조절하는 cytokine 을 
생성한다 . 대식세포 (U937)에 5 nm 은나노입자를 투여하면 IL-8 생성이 
유도되는데 이는 은나노입자의 탐식 및 세포 내 이입에 의하여 
매개됨을 확인하였다 . 
본 연구를 통하여 은나노입자는 세포독성을 유발하지 않는 낮은 
농도에서 면역세포의 기능을 활성화시키고 , 아토피 질환을 
악화시켰으며 이 효과는 은나노입자의 크기가 작을수록 더욱 높아짐을 
파악하였다 . 이러한 결과는 나노물질의 면역 독성 또는 면역계 
활성화의 기전을 이해하고 , 유해성 평가법 개발에 필요한 정보를 
제공할 수 있을 것으로 기대한다 . 
 
 
핵심어 : 은나노입자, 비반세포, 대식세포, 아토피 동물 모델, 활성산소, 싸이토카인. 
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